Leinco Technologies offers recombinant chimeric antibodies which offer many advantages over those produced from traditional hybridoma technology.
mAbMods™ Chimeric Anti-Mouse Antibodies
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development
In vivo antibody studies offer a wide range of applications. Discover the significant impact of antibody selection on your experiment.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Monoclonal vs. Polyclonal Antibodies
Leinco manufactures an extensive range of primary antibodies with the highest purity specifications available in the research products industry.
PhenoCycler-Fusion (CODEX)® Technology and Workflow Steps
PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.
Secondary Antibodies
Leinco Technologies offers a wide range of second step reagents including secondary antibodies, streptavidin and UltraAvidin™.
In vivo GOLD™ vs. In vivo PLATINUM™ Antibodies
Leinco Technologies provides in vivo functional grade antibodies with the highest purity standards in the industry: In vivo GOLDTM & In vivo PLATINUMTM.
Why should you use Isotype Control Antibodies – MBL
Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.
My Cites are Set on You!
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
Deliver Functional Proteins and Antibodies into Living Cells
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.